... in the next few years, with a number of patent expiries and anticipated new drug approvals. The market for Alzheimer's disease has not seen any recent major breakthroughs, and is expected to experience a decline due to the patent expiry of several ...
http://www.sbwire.com/press-releases/neurodegenerative-diseases-market-to-2018-new-product-entries-in-both-niche-and-broader-parkinsons-disease-treatment-will-boost-market-despite-patent-cliff-new-market-report-237345.htm
http://www.sbwire.com/press-releases/neurodegenerative-diseases-market-to-2018-new-product-entries-in-both-niche-and-broader-parkinsons-disease-treatment-will-boost-market-despite-patent-cliff-new-market-report-237345.htm
No comments:
Post a Comment